Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3402/jmahp.v1i0.22799 http://scihub22266oqcxt.onion/10.3402/jmahp.v1i0.22799 C4865742!4865742!27226824     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Mark+Access+Health+Policy 2013 ; 1 (ä): ä Nephropedia Template TP {{tp|p=27226824|t=2013. Delay and restricted access of new molecules in Turkey compared to the United States and European Union |pdf=|usr=}}{{27226824}} gab.com Text Delay and restricted access of new molecules in Turkey compared to the United States and European Union JO: J Mark Access Health Policy http://www.kidney.de/pget.php?&tw=1&pmid=27226824 #FOAvip Objective: This study compares the performances of new-molecule (NM) launches in Turkey with those in the European Union and United States for the years 2007?2013. Methods: The Thomson Reuters Newport Horizon for Innovators Database is used to identify NMs with a launch date after January 1, 2007, worldwide and marketing authorization approval after January 1, 2007, in the European Union. The launch dates for the European Union, the United States, and Turkey were retrieved from the same database. Data for Turkey were confirmed via IMS and RxMedia. Results: Out of 183 records identified that are launched in the European Union, the United States, or both, 44 of the NMs are launched in Turkey (24%). Conclusion: The results of this study show that 24% of the NMs that are launched in either the European Union or United States were able to be launched in Turkey with a mean delay of 821 days (2.25 years). Twit Text FOAVip Delay and restricted access of new molecules in Turkey compared to the United States and European Union ????J Mark Access Health Policy http://www.kidney.de/pget.php?&tw=1&pmid=27226824 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27226824 #FOAvip English Wikipedia <ref>{{Cite pmid|27226824}}</ref> Delay and restricted access of new molecules in Turkey compared to the United States and European Union #MMPMID27226824 ?ahin T; Ye?il A; Topcu T J Mark Access Health Policy 2013[]; 1 (ä): ä PMID27226824show ga Objective: This study compares the performances of new-molecule (NM) launches in Turkey with those in the European Union and United States for the years 2007?2013. Methods: The Thomson Reuters Newport Horizon for Innovators Database is used to identify NMs with a launch date after January 1, 2007, worldwide and marketing authorization approval after January 1, 2007, in the European Union. The launch dates for the European Union, the United States, and Turkey were retrieved from the same database. Data for Turkey were confirmed via IMS and RxMedia. Results: Out of 183 records identified that are launched in the European Union, the United States, or both, 44 of the NMs are launched in Turkey (24%). Conclusion: The results of this study show that 24% of the NMs that are launched in either the European Union or United States were able to be launched in Turkey with a mean delay of 821 days (2.25 years). äDelay and restricted access of new molecules in Turkey compared to the(epmc).pdf DeepDyve Pubget Overpricing